Source: Hematology. Unidade: FM
Subjects: TOMOGRAFIA, DOENÇA DE HODGKIN, MEDULA ÓSSEA, LINFOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERCI, Juliano Júlio e SAPIENZA, Marcelo Tatit. Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group. Hematology, v. 40, n. 3, p. 245-249, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2018.03.002. Acesso em: 21 maio 2024.APA
Cerci, J. J., & Sapienza, M. T. (2018). Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group. Hematology, 40( 3), 245-249. doi:10.1016/j.htct.2018.03.002NLM
Cerci JJ, Sapienza MT. Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group [Internet]. Hematology. 2018 ; 40( 3): 245-249.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.htct.2018.03.002Vancouver
Cerci JJ, Sapienza MT. Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group [Internet]. Hematology. 2018 ; 40( 3): 245-249.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.htct.2018.03.002
